CATALOGO DEI PRODOTTI DELLA RICERCA

Bagante, Fabio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.091
NA - Nord America 3.644
AS - Asia 2.444
SA - Sud America 247
AF - Africa 31
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 6
Totale 10.471
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.616
CN - Cina 1.185
GB - Regno Unito 1.153
SG - Singapore 940
IT - Italia 682
IE - Irlanda 405
RU - Federazione Russa 397
DE - Germania 366
SE - Svezia 352
FR - Francia 339
BR - Brasile 217
FI - Finlandia 168
UA - Ucraina 91
HK - Hong Kong 85
TR - Turchia 69
KR - Corea 64
NL - Olanda 29
BE - Belgio 21
AT - Austria 20
CA - Canada 19
VN - Vietnam 16
CZ - Repubblica Ceca 15
IQ - Iraq 13
AR - Argentina 12
JP - Giappone 12
CH - Svizzera 11
IN - India 10
MA - Marocco 9
RO - Romania 9
TG - Togo 9
EU - Europa 7
ID - Indonesia 7
CO - Colombia 6
AU - Australia 5
AZ - Azerbaigian 5
BD - Bangladesh 5
EC - Ecuador 5
SC - Seychelles 5
UZ - Uzbekistan 5
EE - Estonia 4
ES - Italia 4
MX - Messico 4
AE - Emirati Arabi Uniti 3
EG - Egitto 3
PE - Perù 3
PK - Pakistan 3
PS - Palestinian Territory 3
SK - Slovacchia (Repubblica Slovacca) 3
ZA - Sudafrica 3
CR - Costa Rica 2
JM - Giamaica 2
KZ - Kazakistan 2
LT - Lituania 2
LU - Lussemburgo 2
LV - Lettonia 2
MD - Moldavia 2
MY - Malesia 2
NO - Norvegia 2
NP - Nepal 2
PL - Polonia 2
RS - Serbia 2
SA - Arabia Saudita 2
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
CL - Cile 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GE - Georgia 1
HR - Croazia 1
HU - Ungheria 1
IR - Iran 1
KE - Kenya 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
ME - Montenegro 1
MK - Macedonia 1
MM - Myanmar 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
QA - Qatar 1
SY - Repubblica araba siriana 1
TW - Taiwan 1
UY - Uruguay 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 10.471
Salva come PNG Salva come JPEG
Città #
Southend 1.100
Chandler 704
Singapore 575
Dublin 403
Jacksonville 399
Woodbridge 320
Beijing 249
Ashburn 229
Ann Arbor 160
Houston 156
Lawrence 150
Princeton 150
Verona 137
Wilmington 135
Munich 108
Helsinki 105
Nanjing 94
Jinan 91
Hong Kong 85
Shenyang 68
New York 66
The Dalles 49
Tianjin 49
Sindelfingen 46
Hebei 42
Milan 38
Ningbo 36
Nanchang 34
Changsha 31
Redwood City 31
Santa Clara 31
Seattle 31
Rome 28
Council Bluffs 27
Norwalk 27
Zhengzhou 27
Falls Church 26
Taizhou 26
Boardman 23
Guangzhou 21
Haikou 21
Hangzhou 20
Washington 20
Moscow 19
Seoul 19
Brussels 17
Cambridge 17
Taiyuan 17
Jiaxing 16
Brno 15
Los Angeles 15
Bologna 14
Vienna 14
Dong Ket 13
Redmond 13
Lanzhou 12
Nuremberg 12
Dallas 11
São Paulo 11
Tokyo 11
Zurich 11
Düsseldorf 10
Fairfield 10
Cagliari 9
Lomé 9
London 9
Brasília 8
Campinas 8
Fuzhou 8
Lancaster 8
Lappeenranta 8
Ottawa 8
Chicago 7
Dongguan 7
Frankfurt am Main 7
Napoli 7
Toronto 7
Belo Horizonte 6
Bogotá 6
Esslingen am Neckar 6
Florence 6
Jyväskylä 6
San Diego 6
Shanghai 6
Stockholm 6
Baku 5
Dearborn 5
Jakarta 5
Kent 5
Padova 5
Rio de Janeiro 5
Tashkent 5
Wuhan 5
Arona 4
Auburn 4
Baghdad 4
Bari 4
Como 4
Genoa 4
Groningen 4
Totale 6.671
Salva come PNG Salva come JPEG
Nome #
Evaluation of the ACS NSQIP Surgical Risk Calculator in Elderly Patients Undergoing Hepatectomy for Hepatocellular Carcinoma 437
'Recurrence of cholangiocarcinoma after surgical treatment: an analysis of modes of occurrence, risk factors, and results of treatment. 239
Extranodal extension of lymph node metastasis is a marker of poor prognosis in oesophageal cancer: a systematic review with meta-analysis 194
A re-emerging marker for prognosis in hepatocellular carcinoma: the add-value of fishing c-myc gene for early relapse. 178
Assessment of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and platelet count as predictors of long-term outcome after R0 resection for colorectal cancer 151
A novel serum marker for biliary tract cancer: diagnostic and prognostic values of quantitative evaluation of serum mucin 5AC (MUC5AC) 131
Prognostic value of portal hypertension after surgical resection of HCC in cirrhotic patients 127
Extra-nodal extension of sentinel lymph node metastasis is a marker of poor prognosis in breast cancer patients: A systematic review and an exploratory meta-analysis 127
development of two nomograms for predicting major adverse cardiac events and death in patients admitted to the emergency department with chest pain 125
Impact of age on short-term outcomes of liver surgery: Lessons learned in 10-years' experience in a tertiary referral hepato-pancreato-biliary center 120
Pancreatic resections in patients who refuse blood transfusions. The application of a perioperative protocol for a true bloodless surgery 119
Patterns and prognostic significance of lymph node dissection for surgical treatment of perihilar and intrahepatic cholangiocarcinoma. 118
Hepatolithiasis-associated cholangiocarcinoma: results from a multi-institutional national database on a case series of 23 patients. 115
A Novel Nomogram to Predict the Prognosis of Patients Undergoing Liver Resection for Neuroendocrine Liver Metastasis: an Analysis of the Italian Neuroendocrine Liver Metastasis Database 115
Patterns and prognostic significance of lymph-node dissection for surgical treatment of peri-hilar and intrahepatic cholangiocarcinoma 113
Usefulness of contrast-enhanced intraoperative ultrasonography (CE-IOUS) in patients with colorectal liver metastases after preoperative chemotherapy. 108
What is the most accurate lymph node staging method for perihilar cholangiocarcinoma? Comparison of UICC/AJCC pN stage, number of metastatic lymph nodes, lymph node ratio, and log odds of metastatic lymph nodes 102
Assessment of the Lymph Node Status in Patients Undergoing Liver Resection for Intrahepatic Cholangiocarcinoma: the New Eighth Edition AJCC Staging System 101
A Novel Prognostic Score based on Serum Alpha-Fetoprotein, Number of Nodules, and MYC Gene Status Predicts Prognosis of Patients after Liver Resection for Hepatocellular Carcinoma 100
Clinical significance and prognostic relevance of KRAS, BRAF, PI3K and TP53 genetic mutation analysis for resectable and unresectable colorectal liver metastases: A systematic review of the current evidence 98
Perihilar and distal extrahepatic cholangiocarcinomas show different genetic profiles but share MYC copy gain and TP53 mutation as independent poor prognostic markers 98
Surgical Resection Versus Local Ablation for HCC on Cirrhosis: Results from a Propensity Case-Matched Study 96
Comparative performances of the 7th and the 8th editions of the American Joint Committee on Cancer staging systems for intrahepatic cholangiocarcinoma 94
Extranodal Extension of Nodal Metastases Is a Poor Prognostic Indicator in Gastric Cancer: a Systematic Review and Meta-analysis 93
Tu1730 A Clinical Score Predicting the Occurence of Liver-Related Complications Following Hepatectomy 93
Defining the Chance of Statistical Cure Among Patients with Extrahepatic Biliary Tract Cancer 91
Pancreaticoduodenectomy with venous resection and reconstruction: current surgical techniques and associated postoperative imaging findings 91
Artificial neural networks for multi-omics classifications of hepato-pancreato-biliary cancers: towards the clinical application of genetic data 91
Cholangiocarcinoma risk factors and the potential role of aspirin 89
Defining Post Hepatectomy Liver Insufficiency: Where do We stand? 87
Neutrophil-to-lymphocyte Ratio is a Predictive Marker for Invasive Malignancy in Intraductal Papillary Mucinous Neoplasms of the Pancreas 87
Liver Resection for Breast Cancer Liver Metastases A Cost-utility Analysis 85
Impact of Morphological Status on Long-Term Outcome Among Patients Undergoing Liver Surgery for Intrahepatic Cholangiocarcinoma 84
Perihilar Cholangiocarcinoma: Number of Nodes Examined and Optimal Lymph Node Prognostic Scheme 84
Colorectal cancer with microsatellite instability: Right-sided location and signet ring cell histology are associated with nodal metastases, and extranodal extension influences disease-free survival 84
Postoperative Omental Infarct After Distal Pancreatectomy: Appearance, Etiology Management, and Review of Literature 84
Validation of a Nomogram to Predict the Risk of Perioperative Blood Transfusion for Liver Resection 82
Integrating Clinical Data and Molecular Profiling of Hepato-Pancreato-Biliary Cancers: a Surgical-pathological Approach 82
Extranodal extension of nodal metastases is a poor prognostic moderator in non-small cell lung cancer: a meta-analysis 81
Defining Long-Term Survivors Following Resection of Intrahepatic Cholangiocarcinoma 79
A multi-institutional analysis of elderly patients undergoing a liver resection for intrahepatic cholangiocarcinoma 79
The START nomogram for individualized prediction of the probability of unfavorable outcome after intravenous thrombolysis for stroke 78
Intrahepatic Cholangiocarcinoma: Prognosis of Patients Who Did Not Undergo Lymphadenectomy 78
Impact of adjuvant chemotherapy on survival in patients with intrahepatic cholangiocarcinoma: a multi-institutional analysis 77
The Limitations of Standard Clinicopathologic Features to Accurately Risk-Stratify Prognosis after Resection of Intrahepatic Cholangiocarcinoma 76
Surgical Management of Intrahepatic Cholangiocarcinoma in Patients with Cirrhosis: Impact of Lymphadenectomy on Peri-Operative Outcomes 76
The albumin-bilirubin score stratifies the outcomes of Child-Pugh class A patients after resection of hepatocellular carcinoma 76
Defining when to offer operative treatment for intrahepatic cholangiocarcinoma: A regret-based decision curves analysis 75
Primary liver cancer: Prognostic factors and predictive response to therapy 75
Impact of Delta Hemoglobin on Provider Transfusion Practices and Post-operative Morbidity Among Patients Undergoing Liver and Pancreatic Surgery 74
Evaluation of the 8th edition American Joint Commission on Cancer (AJCC) staging system for patients with intrahepatic cholangiocarcinoma: A surveillance, epidemiology, and end results (SEER) analysis 74
Neutrophil-lymphocyte and platelet-lymphocyte ratio as predictors of disease specific survival after resection of adrenocortical carcinoma 73
Implications of Intrahepatic Cholangiocarcinoma Etiology on Recurrence and Prognosis after Curative-Intent Resection: a Multi-Institutional Study 73
Performance of prognostic scores and staging systems in predicting long-term survival outcomes after surgery for intrahepatic cholangiocarcinoma 72
Early Recurrence of Neuroendocrine Liver Metastasis After Curative Hepatectomy: Risk Factors, Prognosis, and Treatment 72
Neuroendocrine liver metastasis: The chance to be cured after liver surgery 71
Prognosis After Resection of Barcelona Clinic Liver Cancer (BCLC) Stage 0, A, and B Hepatocellular Carcinoma: A Comprehensive Assessment of the Current BCLC Classification 71
Role of inflammatory and immune-nutritional prognostic markers in patients undergoing surgical resection for biliary tract cancers 71
Minimally Invasive vs. Open Hepatectomy: a Comparative Analysis of the National Surgical Quality Improvement Program Database 70
Patterns of Distribution of Hepatic Nodules (Single, Satellites or Multifocal) in Intrahepatic Cholangiocarcinoma: Prognostic Impact After Surgery 70
Central Pancreatectomy: from Open to Minimally Invasive 69
Synergistic Effects of Perioperative Complications on 30-Day Mortality Following Hepatopancreatic Surgery 67
Simultaneous approach for patients with synchronous colon and rectal liver metastases: Impact of site of primary on postoperative and oncological outcomes 67
Comparison of the 7th and 8th editions of the American Joint Committee on Cancer Staging Systems for perihilar cholangiocarcinoma 67
The Impact of Discharge Timing on Readmission Following Hepatopancreatobiliary Surgery: a Nationwide Readmission Database Analysis 66
Use of Machine Learning for Prediction of Patient Risk of Postoperative Complications After Liver, Pancreatic, and Colorectal Surgery 66
Quality of life after treatment of neuroendocrine liver metastasis 66
Complications after liver surgery: a benchmark analysis 66
Nomogram to predict perioperative blood transfusion for hepatopancreaticobiliary and colorectal surgery 65
Perioperative and Long-Term Outcome for Intrahepatic Cholangiocarcinoma: Impact of Major Versus Minor Hepatectomy 65
Trends in the Incidence, Treatment and Outcomes of Patients with Intrahepatic Cholangiocarcinoma in the USA: Facility Type is Associated with Margin Status, Use of Lymphadenectomy and Overall Survival 65
Multigene mutational profiling of biliary tract cancer is related to the pattern of recurrence in surgically resected patients 64
Molecular characterization of extrahepatic cholangiocarcinoma: perihilar and distal tumours display divergent genomic and transcriptomic profiles 64
Pancreatic Fistula and Delayed Gastric Emptying After Pancreatectomy: Where do We Stand? 63
Intrahepatic cholangiocarcinoma tumor burden: A classification and regression tree model to define prognostic groups after resection 62
Management and outcomes of patients with recurrent neuroendocrine liver metastasis after curative surgery: An international multi-institutional analysis 61
Surgical Procedures in Health Professional Shortage Areas: Impact of a Surgical Incentive Payment Plan 60
The Impact of Extent of Liver Resection Among Patients with Neuroendocrine Liver Metastasis: an International Multi-institutional Study 60
Outcomes of vascular resection associated with curative intent hepatectomy for intrahepatic cholangiocarcinoma 60
Variation in Medicare Payments and Reimbursement Rates for Hepatopancreatic Surgery Based on Quality: Is There a Financial Incentive for High-Quality Hospitals? 59
Early versus late recurrence of intrahepatic cholangiocarcinoma after resection with curative intent 58
The Cost of Failure: Assessing the Cost-Effectiveness of Rescuing Patients from Major Complications After Liver Resection Using the National Inpatient Sample 58
ASO Author Reflections: Re-resection of Positive Bile Duct Margin for Hilar Cholangiocarcinoma 57
Preoperative Risk Score and Prediction of Long-Term Outcomes after Hepatectomy for Intrahepatic Cholangiocarcinoma 56
A Comparison of Open and Minimally Invasive Surgery for Hepatic and Pancreatic Resections Among the Medicare Population 56
Liver Resection for Neuroendocrine Tumor Liver Metastases Within Milan Criteria for Liver Transplantation 55
Liver transplantation in patients with liver metastases from neuroendocrine tumors 55
The Impact of Dedicated Cancer Centers on Outcomes Among Medicare Beneficiaries Undergoing Liver and Pancreatic Cancer Surgery 55
Patterns of gene mutations in bile duct cancers: is it time to overcome the anatomical classification? 54
Defining the chance of cure after resection for hepatocellular carcinoma within and beyond the Barcelona Clinic Liver Cancer guidelines: A multi-institutional analysis of 1,010 patients 54
Role of Lymph Node Dissection in Small (≤ 3 cm) Intrahepatic Cholangiocarcinoma 53
ASO Author Reflections: Minimally Invasive Surgery for Hepatocellular Carcinoma in the Setting of Portal Vein Hypertension 53
Neuroendocrine Liver Metastasis: Prognostic Implications of Primary Tumor Site on Patients Undergoing Curative Intent Liver Surgery 52
Perioperative use of blood products is associated with risk of morbidity and mortality after surgery 52
Synergistic Impact of Alpha-Fetoprotein and Tumor Burden on Long-Term Outcomes Following Curative-Intent Resection of Hepatocellular Carcinoma 50
Perioperative and long-term outcome of intrahepatic cholangiocarcinoma involving the hepatic hilus after curative-intent resection: comparison with peripheral intrahepatic cholangiocarcinoma and hilar cholangiocarcinoma 50
Short-Term Outcomes of Patients Undergoing Portal Vein Embolization: an ACS-NSQIP Procedure-Targeted Hepatectomy Analysis 50
Impact of histological subtype on the prognosis of patients undergoing surgery for colon cancer 49
The impact of a malignant diagnosis on the pattern and outcome of readmission after liver and pancreatic surgery: An analysis of the nationwide readmissions database 49
Use of perioperative epidural analgesia among Medicare patients undergoing hepatic and pancreatic surgery 49
Totale 8.501
Salva come PNG Salva come JPEG
Categoria #
all - tutte 47.018
article - articoli 44.217
book - libri 0
conference - conferenze 1.870
curatela - curatele 0
other - altro 324
patent - brevetti 0
selected - selezionate 0
volume - volumi 607
Totale 94.036
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020275 0 0 0 0 0 0 0 0 0 45 88 142
2020/20211.208 149 165 32 177 183 145 18 43 79 30 143 44
2021/2022917 106 165 25 63 28 32 24 75 40 31 43 285
2022/20232.317 181 231 241 359 171 609 26 124 261 20 66 28
2023/20241.129 54 93 105 103 159 195 43 112 6 51 140 68
2024/20252.409 185 217 112 560 213 177 166 201 447 131 0 0
Totale 10.682